Balwinder Singh

Dr. Balwinder Singh

Mayo Clinic, Rochester, Indiana, USA
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 January 2014 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
PDF file
BSBalwinder Singh
Balwinder Singh
APAjay K. Parsaik
Ajay K. Parsaik
MMMichelle Mielke
Michelle Mielke
PEPatricia J. Erwin
Patricia J. Erwin
DKDavid S. Knopman
David S. Knopman
RRRosebud O. Roberts
Rosebud O. Roberts
Background/Objective: To conduct a systematic review of all studies to determine whether there is an association between the Mediterranean diet (MeDi) and cognitive impairment. Methods: We conducted a comprehensive search of the major databases and h

11 November 2023 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
MGMichael A Gargano
Michael A Gargano
NMNicolas Matentzoglu
Nicolas Matentzoglu
BCBen Coleman
Ben Coleman
EAEunice B Addo-Lartey
Eunice B Addo-Lartey
AAAnna V Anagnostopoulos
Anna V Anagnostopoulos
PRPeter N. Robinson
Peter N. Robinson
The Human Phenotype Ontology (HPO) is a widely used resource that comprehensively organizes and defines the phenotypic features of human disease, enabling computational inference and supporting genomic and phenotypic analyses through semantic similarity and machine learning algorithms. The HPO has widespread applications in clinical diagnostics and translational research, including genomic diagnostics, gene-disease discovery, and cohort analytics. In recent years, groups around the world have developed translations of the HPO from English to other languages, and the HPO browser has been internationalized, allowing users to view HPO term labels and in many cases synonyms and definitions in ten languages in addition to English. Since our last report, a total of 2239 new HPO terms and 49235 new HPO annotations were developed, many in collaboration with external groups in the fields of psychiatry, arthrogryposis, immunology and cardiology. The Medical Action Ontology (MAxO) is a new effort to model treatments and other measures taken for clinical management. Finally, the HPO consortium is contributing to efforts to integrate the HPO and the GA4GH Phenopacket Schema into electronic health records (EHRs) with the goal of more standardized and computable integration of rare disease data in EHRs.

2 January 2022 in Journal of Affective Disorders
Verified
Journal Article
Closed access
NNNicolas A Nuñez
Nicolas A Nuñez
BJBoney Joseph
Boney Joseph
MPMehak Pahwa
Mehak Pahwa
RKRakesh Kumar
Rakesh Kumar
MRManuel Gardea Resendez
Manuel Gardea Resendez
BSBalwinder Singh
Balwinder Singh

1 September 2012 in Mayo Clinic Proceedings
Verified
Journal Article
Closed access
BSBalwinder Singh
Balwinder Singh
ASAmandeep Singh
Amandeep Singh
AAAdil Ahmed
Adil Ahmed
GWGregory A. Wilson
Gregory A. Wilson
BPBrian W. Pickering
Brian W. Pickering
GLGuangxi Li
Guangxi Li

1 April 2014 in The American Journal of Cardiology
Verified
Journal Article
Closed access
KSKuljit Singh
Kuljit Singh
KCKristin Carson-Chahhoud
Kristin Carson-Chahhoud
RSRanjit Shah
Ranjit Shah
GSGagandeep Sawhney
Gagandeep Sawhney
BSBalwinder Singh
Balwinder Singh
JHJohn Horowitz
John Horowitz

1 May 2014 in JAMA Neurology
Verified
Journal Article
Open access
PDF file
BSBalwinder Singh
Balwinder Singh
MMMichelle Mielke
Michelle Mielke
APAjay K. Parsaik
Ajay K. Parsaik
RCRuth H. Cha
Ruth H. Cha
RRRosebud O. Roberts
Rosebud O. Roberts
RPRonald C. Petersen
Ronald C. Petersen
Chronic obstructive pulmonary disease (COPD) is a progressive but potentially treatable and preventable disease characterized by chronic airflow limitation and associated with an abnormal inflammatory response of the lungs to noxious particles or gases.1 Current surveillance data show that more than 13.5 million adults 25 years and older in the United States have COPD.2 Chronic airflow limitation can result in hypoxemia and hypercapnia, which may predispose these patients to an increased risk for cognitive dysfunction.3,4